Yimin Chen
Guiyang, 550001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
USP5 stabilizes RSK1 and promotes temozolomide resistance in glioblastoma.
Journal: Biochemical and biophysical research communications
Published: February 14, 2026
JOSD1 Deubiquitinates Twist1 and Facilitates Epithelial-Mesenchymal Transition in Glioblastoma.
Journal: Cell biochemistry and function
Published: November 26, 2025
Persistence of the coccidiostat robenidine in soil and its impacts on the soil microbiome and enzyme functions.
Journal: Ecotoxicology and environmental safety
Published: June 05, 2025
USP14-mediated stabilization of ACTN1 maintains mesenchymal characteristics in glioblastoma.
Journal: Communications biology
Published: March 29, 2025
ATXN3 deubiquitinates ZEB1 and facilitates epithelial-mesenchymal transition in glioblastoma.
Journal: Scientific reports
Published: October 17, 2024
Erratum: [Corrigendum] Aloperine activates the Nrf2‑ARE pathway when ameliorating early brain injury in a subarachnoid hemorrhage model.
Journal: Experimental and therapeutic medicine
Published: May 17, 2024
USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.
Journal: Cell death & disease
Published: November 06, 2022
PRL1 Promotes Glioblastoma Invasion and Tumorigenesis via Activating USP36-Mediated Snail2 Deubiquitination.
Journal: Frontiers in oncology
Published: October 15, 2021
Hypoxia-induced EPHB2 promotes invasive potential of glioblastoma.
Journal: International journal of clinical and experimental pathology
Published: September 07, 2018
Aloperine activates the Nrf2-ARE pathway when ameliorating early brain injury in a subarachnoid hemorrhage model.
Journal: Experimental and therapeutic medicine
Published: January 29, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026